Cohort Study of Insulin Glargine and Risk of Breast Prostate and Colorectal Cancer Among Patients With Diabetes

摘要

OBJECTIVETo examine whether use of insulin glargine, compared with another long-acting insulin, is associated with risk of breast, prostate, colorectal cancer, or all cancers combined.